Prognostic factor†| Both sexes (n = 101) | Males (n- = 49) | Females (n = 52) | |||
---|---|---|---|---|---|---|
 | Effect on RMDQ (95%CI) | (p) | Effect on RMDQ (95%CI) | (p) | Effect on RMDQ (95%CI) | (p) |
In post-workshops Cohort (y/n) | -1.433 (-3.25-0.39) | 0.121 | -1.142 (-4.17-1.89) | 0.451 | -2.897 (-5.32- -0.47) | 0.020 |
RMDQ baseline score (/24) | 0.299 (0.10-0.50) | 0.003 | 0.362 (0.05-0.68) | 0.026 | 0.086 (-1.9-0.36) | 0.535 |
Downhearted (/5) | 0.991 (0.26-1.72) | 0.008 | 0.503 (-0.67-1.68) | 0.451 | 1.634 (0.66-2.61) | 0.002 |
Self-rated health (/4) | -1.245 (-2.27- -0.22) | 0.018 | -1.368 (-2.85-0.11) | 0.069 | -1.524 (-3.09-0.05) | 0.056 |
Leg pain bothersomeness (/4) | 0.644 (-0.03-1.32) | 0.063 | 0.323 (-0.68-1.33) | 0.520 | 1.431 (0.43-2.44) | 0.006 |
Episode duration (/12) | 0.270 (-0.06-0.60) | 0.106 | 0.404 (-0.14-0.95) | 0.140 | 0.074 (-0.52-0.37) | 0.741 |